{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:10:06Z","timestamp":1767946206909,"version":"3.49.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study investigated whether employment status moderates associations between baseline serum biomarkers and antidepressant remission at 12 weeks and 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective cohort of 1086 outpatients diagnosed with depressive disorders received stepwise antidepressant therapy using a naturalistic, flexible treatment protocol. Fourteen serum biomarkers covering immune (hsCRP, TNF-\u03b1, IL-1\u03b2, IL-6, IL-4, IL-10), metabolic (leptin, ghrelin, total cholesterol), neuroplastic (BDNF), neurotransmitter (serotonin), endocrine (cortisol), and nutritional (folate, homocysteine) domains were analyzed at baseline. Employment-dependent biomarker associations with remission (Hamilton Depression Rating Scale \u22647) at 12 weeks and 12 months were evaluated using logistic regression with biomarker-by-employment interactions and stratified analyses, adjusting for relevant covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Higher serotonin levels significantly predicted 12-week remission exclusively among employed patients, with a significant employment interaction. At 12 months, lower leptin levels predicted remission specifically in employed patients, whereas lower TNF-\u03b1 and higher BDNF levels predicted remission only in unemployed patients, each demonstrating significant employment interactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Baseline serum biomarkers showed employment-dependent associations with antidepressant remission outcomes, highlighting serotonin\u2019s short-term relevance and leptin, TNF-\u03b1, and BDNF as longer-term indicators. Although exploratory, these findings suggest that integrating employment status with biomarker profiles may enhance clinical decision-making by identifying patients who are more or less likely to benefit from treatment across different phases of recovery. Replication in independent cohorts is needed to establish the clinical applicability of such employment-tailored, biomarker-informed strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1662993","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:41:42Z","timestamp":1767940902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Employment-dependent associations of serum biomarkers with short- and long-term antidepressant treatment outcomes"],"prefix":"10.3389","volume":"16","author":[{"given":"Jae-Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Ju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Jhon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il-Seon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1455122","article-title":"The protective role of employment in depression: insights from 2005 to 2018 NHANES information","volume":"15","author":"Li","year":"2024","journal-title":"Front Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21573","DOI":"10.1038\/s41598-022-25775-1","article-title":"Unemployment and hair cortisol as a biomarker of chronic stress","volume":"12","author":"Lawes","year":"2022","journal-title":"Sci Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.18091079","article-title":"General predictors and moderators of depression remission: A VAST-D report","volume":"176","author":"Zisook","year":"2019","journal-title":"Am J Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2014-204404","article-title":"Elevated inflammatory biomarkers during unemployment: modification by age and country in the UK","volume":"69","author":"Hughes","year":"2015","journal-title":"J Epidemiol Community Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0160455","DOI":"10.1371\/journal.pone.0160455","article-title":"Socioeconomic disadvantage moderates the association between peripheral biomarkers and childhood psychopathology","volume":"11","author":"Mansur","year":"2016","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1080\/10253890701754068","article-title":"A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression","volume":"11","author":"Miura","year":"2008","journal-title":"Stress"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/nu15112433","article-title":"Dietary nutrient deficiencies and risk of depression","volume":"15","author":"Zieli\u0144ska","year":"2023","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bbi.2022.05.012","article-title":"Prospective associations of multimodal serum biomarkers with 12-week and 12-month remission in patients with depressive disorders receiving stepwise psychopharmacotherapy","volume":"104","author":"Kim","year":"2022","journal-title":"Brain Behav Immun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.30773\/pi.2017.10.2","article-title":"The MAKE Biomarker Discovery for Enhancing AnTidepressant Treatment Effect and Response (MAKE BETTER) Study: design and methodology","volume":"15","author":"Kang","year":"2018","journal-title":"Psychiatry Investig"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.05.002","article-title":"Short and long-term treatment outcomes of stepwise psychopharmacotherapy based on early clinical decision in patients with depressive disorders","volume":"274","author":"Kim","year":"2020","journal-title":"J Affect Disord"},{"key":"B11","volume-title":"Diagnostic and statistical manual of mental disorders","year":"2000"},{"key":"B12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/iop.2021.94","article-title":"Job analysis and job classification for addressing pay inequality in organizations: Adjusting our methods within a shifting legal landscape","volume":"15","author":"Strah","year":"2022","journal-title":"IO Psychol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.09.067","article-title":"A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder","volume":"243","author":"Perlman","year":"2019","journal-title":"J Affect Disord"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.1995.56.423","article-title":"The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings","volume":"56","author":"Bohn","year":"1995","journal-title":"J Stud Alcohol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2013.804195","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders","volume":"14","author":"Bauer","year":"2013","journal-title":"World J Biol Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/hup.1168","article-title":"Predictors of 12-week remission in a Nationwide cohort of people with depressive disorders: the CRESCEND study","volume":"26","author":"Kim","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0585-z","article-title":"Prospective biomarkers of major depressive disorder: A systematic review and meta-analysis","volume":"25","author":"Kennis","year":"2020","journal-title":"Mol Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am J Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1416866112","article-title":"Brain 5-HT deficiency increases stress vulnerability and impairs antidepressant responses following psychosocial stress","volume":"112","author":"Sachs","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2013-101891","article-title":"Health effects of employment: a systematic review of prospective studies","volume":"71","author":"van der Noordt","year":"2014","journal-title":"Occup Environ Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2022.20.2.248","article-title":"Associations of serum serotonin levels with 12-week and 12-month remission in patients with depressive disorders","volume":"20","author":"Choi","year":"2022","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-66","article-title":"Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways","volume":"10","author":"Maes","year":"2012","journal-title":"BMC Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-410","article-title":"Unemployment and ill health: a connection through inflammation","volume":"9","author":"Hintikka","year":"2009","journal-title":"BMC Public Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41419-018-1129-1","article-title":"Leptin in depression: a potential therapeutic target","volume":"9","author":"Ge","year":"2018","journal-title":"Cell Death Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0187448","DOI":"10.1371\/journal.pone.0187448","article-title":"The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women","volume":"12","author":"Webb","year":"2017","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1186\/s12889-022-14518-6","article-title":"Systematic realist synthesis of health-related and lifestyle interventions designed to decrease overweight, obesity and unemployment in adults","volume":"22","author":"Amenyah","year":"2022","journal-title":"BMC Public Health"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313098","article-title":"Variations in BDNF and their role in the neurotrophic antidepressant mechanisms of ketamine and esketamine: A review","volume":"25","author":"Pardossi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2024.107192","article-title":"Dynamic interplay of cortisol and BDNF in males under acute and chronic psychosocial stress - A randomized controlled study","volume":"170","author":"Herhaus","year":"2024","journal-title":"Psychoneuroendocrinology"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1662993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:41:43Z","timestamp":1767940903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1662993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":30,"alternative-id":["10.3389\/fpsyt.2025.1662993"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1662993","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1662993"}}